Cholesterol

Especificaciones

57-88-5Número CAS

200-353-2Número CE

(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-olNombre IUPAC

C27H46OFórmula química

386.7 g/molPeso molecular

cholesterol; 57-88-5; Cholesterin; Cholest-5-en-3beta-ol; Cholesteryl alcohol; Dythol; Cordulan; Dusoline; Dusoran; Cholesterine; Cholestrin; Cholestrol; Hydrocerin; Lidinite; Kathro; Lanol; Super hartolan; Lidinit; Cholesterol base H; Nimco cholesterol base H; (-)-Cholesterol; 3beta-Hydroxycholest-5-ene; Tegolan; 5:6-Cholesten-3beta-ol; (3beta)-cholest-5-en-3-ol; Provitamin-d; Cholest-5-en-3-ol (3beta)-; NSC 8798; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; 5-Cholesten-3B-ol; DTXSID3022401; AI3-03112; NSC-8798; 97C5T2UQ7J; CHEBI:16113; NSC8798; DTXCID402401; (3beta,14beta,17alpha)-cholest-5-en-3-ol; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((2R)-6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-3-ol; 10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-3-ol; 10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; Cholesterol 1551; RefChem:6411; (1S,2R,10S,11S,14R,15R)-2,15-dimethyl-14-((2R)-6-methylheptan-2-yl)tetracyclo(8.7.0.02,7.011,15)heptadec-7-en-5-ol; 200-353-2; Cholesterinum; Tegolan (VAN); Cholest-5-en-3-beta-ol; 3-beta-Hydroxycholest-5-ene; Cholest-5-en-3-ol (3.beta.)-; 5-Cholesten-3beta-ol; CCRIS 2834; Dastar; HSDB 7106; delta(sup 5)-Cholesten-3-beta-ol; Fancol CH; 3beta-Hydroxy-5-cholestene; 3h-cholesterol; MFCD00003646; Cholest-5-en-3-ol; Cholesterol (Standard); Nimco cholesterol base No. 712; Cholesterol (Excipient); 5:6-Cholesten-3-ol; 5-Cholesten-3.beta.-ol; Cholest-5-en-3.beta.-ol; 5,6-Cholesten-3.beta.-ol; 3.beta.-Hydroxycholest-5-ene; (1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol; 129111-15-5; C27H46O; NCGC00159351-02; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3.beta.)-cholest-5-en-3-ol; Cholesterol-t; (3S,8S,9S,10R,13R,14S,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3H)-Cholesterol; Cholest-5-en-3-ol, (3beta)-; EINECS 200-353-2; epicholesterin; UNII-97C5T2UQ7J; Cholesterol [BAN:JAN:NF]; Cholesterol?; .DELTA.5-Cholesten-3-.beta.-ol; Cholesterol CRS; 80356-14-5; 1zhy; Cholest-5-en-3-ol, (3.beta.)- #; 20-epi-cholesterol; 20-iso-cholesterol; Cholesterol, 94%; Liquid crystal CN/9; (+)-ent-Cholesterol; cholest-5-en-3b-ol; 5-Cholesten-3ss--ol; 5-cholestene-3beta-ol; Cholesterol in Methanol; Cholesterol (>99%); Cholesterol, 99.0%; CHOLESTEROL [II]; CHOLESTEROL [MI]; ALF component cholesterol; CHOLESTEROL [JAN]; Cholesterol (animal-free); Cholesterol (plant-based); ALFQ component cholesterol; Cholesterol (JP18/NF); 57-88-5(solution); CHOLESTEROL [HSDB]; CHOLESTEROL [IARC]; Phospholipon & Cholesterol; Cholesterol, Plant-Derived; Delta5-Cholesten-3beta-ol; Epitope ID:150761; CHOLESTEROL [VANDF]; EC 200-353-2; 3beta-cholest-5-en-3-ol; 3ss--Hydroxy-5-cholestene; Cholesterol (for injection); SCHEMBL2156; ALF43 component cholesterol; CHOLESTERINUM [HPUS]; CHOLESTEROL [MART.]; BIDD:PXR0095; (3b)-cholest-5-en-3-ol; CHOLESTEROL [USP-RS]; CHOLESTEROL [WHO-DD]; 3beta-hydroxy-cholesta-5-ene; 5:6-Cholesten-3.beta.-ol; 20bFH-cholest-5-en-3b-ol; BIDD:ER0548; Cholest-5-en-3-ol (3beta)-, labeled with tritium; (3|A)-cholest-5-en-3-ol; CHEMBL112570; GTPL2718; orb1224601; orb1310316; orb3139450; SCHEMBL9501738; SCHEMBL22206715; SCHEMBL28302508; SCHEMBL31229441; BDBM20192; HY-N0322B; HY-N0322R; (20bFH)-cholest-5-en-3b-ol; CHEBI:140435; CHOLESTEROL [EP MONOGRAPH]; Cholesterol, Sigma Grade, >=99%; HY-N0322; Cholesterol (formerly GBW09203b); Tox21_111595; CMC_13392; EBC-03865; LMST01010001; MSK000797; s4154; SBB058670; AKOS005267135; Cholest-5-en-3-ol, (3-.beta.)-; CS-5106; DB04540; FC28806; GS-6857; CAS-57-88-5; Cholesterol 10 |Ig/mL in Acetonitrile; Cholesterol, NIST(R) SRM(R) 911c; SMP1_000069; NCGC00159351-03; (1R,3aS,3bS,7S,9aR,9bS,11aR)-9a,11a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol; 22243-67-0; BP-26125; Cholesterol 10 microg/mL in Acetonitrile; Cholesterol, tested according to Ph.Eur.; SY012864; C3624; Cholesterol, from lanolin, >=95.0% (GC); Cholesterol, from lanolin, >=99.0% (GC); CS-1096707; NS00005787; T0760; Army Liposome Formulation component cholesterol; C00187; D00040; EN300-323186; F70214; Q43656; AB00443913_03; Cholesterol, >=95% (GC), powder, Ash, free; Cholesterol, Vetec(TM) reagent grade, >=92.5%; F121530; Soya phospholipon & Cholesterol (2:1 molar ratio); 5BBA213B-ECF4-44AF-8AAF-8A0120F2F886; WLN: L E5 B666 LUTJ A1 E1 FY1&3Y1&1 OQ; Z2033589790; Cholesterol, powder, BioReagent, suitable for cell culture, >=99%; Cholesterol, United States Pharmacopeia (USP) Reference Standard; Cholesterol, Pharmaceutical Secondary Standard; Certified Reference Material; Cholesterol; Cholest-5-en-3-ol; (3beta)-Cholest-5-en-3-ol; Cholesteryl alcohol; 14-((1R)-1,5-dimethylhexyl)(1S,5S,10S,11S,2R,14R,15R)-2,15-dimethyltetracyclo[ 8.7.0.0<2,7>.0<11,15>]heptadec-7-en-5-olSinónimos